Aug 2026· Science of the Total Environment· Vol 1049, pp.
182177
· 0 citations· 24 references
Medicine
TL;DR
Higher urinary concentrations of specific DAP metabolites were associated with microalbuminuria and kidney hyperfiltration in U.S. children, highlighting the potential kidney effects of early-life organophosphate pesticide exposure and warrant further investigation into underlying mechanisms.
Abstract
Recent evidence links organophosphate pesticide exposure to cardiometabolic and kidney disorders in adults, but its impact in children remains poorly understood. This study evaluated associations between urinary dialkyl phosphate (DAP) metabolite concentrations and early markers of kidney and cardiovascular stress in children. A nationwide population sample of 2928 children less than 18 years of age from the 2015-2020 National Health and Nutrition Examination Survey (NHANES) was evaluated. The six DAP metabolites examined were dimethylphosphate (DMP), diethylphosphate (DEP), dimethylthiophosphate (DMTP), diethylthiophosphate (DETP), dimethyldithiophosphate (DMDTP) and diethyldithiophosphate (DEDTP). Clinical outcomes measured included both systolic and diastolic blood pressure indices, hypertensive status, microalbuminuria (albumin-to-creatinine ratio greater than 30 mg/g), and kidney hyperfiltration (estimated glomerular filtration rate greater than 135 mL/min/1.73m2). Multivariate linear and logistic regression models were used with adjustments made for age, gender, body mass index z-score, and poverty income ratio to evaluate the relationships among each of these clinical outcomes and levels of the metabolites. Statistical significance was set at p < 0.0167 due to the number of comparisons made. In adjusted models, higher urinary DAP metabolite concentrations were not significantly associated with systolic or diastolic blood pressure indices or hypertensive status (p > 0.05). However, higher DEDTP was significantly associated with both microalbuminuria (OR 1.290, 95% CI [1.051-1.583], p = 0.016) and kidney hyperfiltration (OR 2.348, 95% CI [1.658-3.324], p < 0.001). Additionally, higher DMDTP was significantly associated with hyperfiltration (OR 1.466, 95% CI [1.116-1.926], p = 0.007). In conclusion, higher urinary concentrations of specific DAP metabolites were associated with microalbuminuria and kidney hyperfiltration in U.S. children. These findings highlight the potential kidney effects of early-life organophosphate pesticide exposure and warrant further investigation into underlying mechanisms.
In this adult U.S. sample, detectable serum aflatoxin B1-lysine was rare and not associated with markers of kidney dysfunction, meaning that the findings are inconclusive rather than definitive evidence of no renal effect.
A. Alkhatib· Journal of Clinical Nephrolo...· 0 citations
It is suggested that mixed PFAS exposure, particularly to PFOA and PFHpA, may induce impaired renal function, with increased blood lipids playing an important mediating role.
Dandan Xu, Z. Mo, Jie Xiang et al.· Environmental Pollution· 0 citations
The findings should be interpreted as hypothesis-generating and suggest that adults without diabetes but with clustered metabolic abnormalities may warrant further longitudinal evaluation for kidney risk stratification.
Xiao-Han Xu, Shan-Hu Qiu, Xiao-Ying Zhou et al.· Journal of Endocrinological...· 0 citations
In this large cohort, across the entire range of gold-standard measured GFR, hyperkalemia is driven primarily by reduced kidney function, diabetes, and RAASi, whereas protective factors were female sex, sub-Saharan African ancestry, and loop diuretic therapy.
Justina Motiejunaite, M. Flamant, Alexandre Lahens et al.· American Journal of Nephrolo...· 0 citations
Despite decades of clinical use, serum creatinine and cystatin C remain imperfect indicators of kidney function, being influenced by muscle mass, age, sex, and inflammation and often showing limited sensitivity to early renal injury. D-amino acids (D-AAs), once largely regarded as by-products of microbial metabolism, h...
Alina Uifălean, M. Iacobescu, X. Mureșan et al.· Pharmaceutics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.